Condition
Keloid Scars
Total Trials
5
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 65/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
60%
3 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
5Total
P 1 (1)
P 2 (1)
P 3 (1)
P 4 (2)
Trial Status
Recruiting2
Not Yet Recruiting1
Terminated1
Active Not Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07336368Phase 3RecruitingPrimary
Topical Cryotherapy and Keloid/Hypertrophic Scars
NCT06751433Phase 1Recruiting
Evaluation of Clinical, Perceived and Instrumental Efficacy of a Scar Gel in Preventing Hypertrophic Scars
NCT06897969Phase 4Not Yet RecruitingPrimary
Comparison of Intralesional Triamcinolone Versus Verapamil for Keloid Treatment
NCT06814288Phase 2Active Not RecruitingPrimary
The Effectiveness of Intralesional Botulinum Toxin A and Triamcinolone Acetonide Injections in Keloid Treatment
NCT01720056Phase 4TerminatedPrimary
Verapamil vs Steroid to Prevent Keloid Recurrence
Showing all 5 trials